Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
openAccess | | 5-feb-2020 | CDC-7-inhibitors compounds and use thereof for the treatment of neurological conditions | Martínez Gil, Ana CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Pérez, Concepción CSIC ORCID | solicitud de patente |
openAccess | | 27-sep-2018 | CDC-7-inhibitors compounds and use thereof for the treatment of neurological conditions | Martínez Gil, Ana CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Pérez, Concepción CSIC ORCID | solicitud de patente |
openAccess | | 26-mar-2020 | CDC-7-inhibitors compounds and use thereof for the treatment of neurological conditions | Martínez Gil, Ana CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Pérez, Concepción CSIC ORCID | solicitud de patente |
openAccess | | 26-mar-2020 | CDC7-Inhibiting purine derivatives and their use for the treatment of neurological conditions | Martínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; Martín Requero, A.; Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID | solicitud de patente |
openAccess | | 22-oct-2018 | Compuestos inhibidores de CDC-7 y su uso para el tratamiento de patologías neurológicas | Martínez Gil, Ana CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Pérez, Concepción CSIC ORCID | patente |
openAccess | | 22-oct-2018 | Compuestos inhibidores de CDC-7 y su uso para el tratamiento de patologías neurológicas | Martínez Gil, Ana CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Pérez, Concepción CSIC ORCID | solicitud de patente |
openAccess | | 23-mar-2020 | Derivados de purina inhibidores de CDC7 y su uso para el tratamiento de patologías neurológicas | Martínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID | patente |
openAccess | | 23-mar-2020 | Derivados de purina inhibidores de CDC7 y su uso para el tratamiento de patologías neurológicas | Martínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID | solicitud de patente |
openAccess | | 11-ene-2024 | Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase | Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Gil, Carmen CSIC ORCID ; Ramírez, David; Martínez Gil, Ana | artículo |
openAccess | | 22-mar-2021 | Improved controlled release and brain penetration of the small molecule S14 using PLGA nanoparticles | Nozal, Vanesa CSIC ORCID; Rojas-Prats, Elisa CSIC ORCID; Maestro, Inés CSIC ORCID; Gil, Carmen CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Martínez Gil, Ana CSIC ORCID | artículo |
openAccess | | 28-ene-2021 | Increasing brain permeability of PHA-767491, a cell division cycle 7 kinase inhibitor, with biodegradable polymeric nanoparticles | Rojas-Prats, Elisa CSIC ORCID; Tosat-Bitrian, Carlota CSIC ORCID ; Martínez-González, Loreto CSIC ORCID ; Nozal, Vanesa CSIC ORCID; Pérez, Daniel I. CSIC ORCID; Martínez Gil, Ana CSIC ORCID | artículo |
openAccess | | 18-jun-2021 | O2 Improved controlled release and brain penetration of small molecules with therapeutic potential using PLGA nanoparticles | Nozal, Vanesa CSIC ORCID; Rojas-Prats, Elisa CSIC ORCID; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID | comunicación de congreso |
openAccess | | 1-ago-2020 | Protein kinase inhibitors for amyotrophic lateral sclerosis therapy | Palomo, Valle CSIC ORCID ; Nozal, Vanesa CSIC ORCID; Rojas-Prats, Elisa CSIC ORCID; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID | artículo |
openAccess | | 15-ene-2021 | Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis | Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Gonzalo-Consuegra, Claudia; Liachko, Nicole F.; Pérez, Concepción CSIC ORCID; Ramírez, David; Kraemer, Brian C.; Martín-Requero, Ángeles CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; De Lago, E.; Martínez Gil, Ana CSIC ORCID | artículo |
openAccess | | sep-2019 | TDP-43 modulation by CDC7 inhibitors as a therapeutic strategy for amyotrophic lateral sclerosis | Rojas-Prats, Elisa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Liachko, Nicole F.; Kraemer, Brian C.; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Martínez Gil, Ana CSIC ORCID | comunicación de congreso |
openAccess | | 17-jul-2020 | Therapeutic potential of novel cell division cycle kinase 7 inhibitors on TDP-43-related pathogenesis such as frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) | Vaca, Gabriela; Martínez-González, Loreto CSIC ORCID ; Fernández, Ana; Rojas-Prats, Elisa CSIC ORCID; Porras, Gracia CSIC ; Cuevas, Eva P. CSIC ORCID ; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID | artículo |